FindTrial
Sign In

Differences in effects of intraoperative cardiopulmonary between conventional vaginal natural orifice transluminal endoscopic surgery (vNOTES) and gasless vNOTES: a prospective randomized controlled clinical study

Differences in effects of intraoperative cardiopulmonary between conventional vaginal natural orifice transluminal endoscopic surgery (vNOTES) and gasless vNOTES: a prospective randomized controlled clinical study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200064779
Enrollment
Unknown
Registered
2022-10-17
Start date
2022-10-17
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynecologic benign diseases

Interventions

Control group:conventional vaginal natural orifice transluminal endoscopic surgery
Intervention group :gasless vaginal natural orifice transluminal endoscopic surgery

Sponsors

Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. 18-60 years old; 2. ASA Level 1-2; 3. BMI 18-25 4. Benign gynecological diseases 5. The patient voluntarily joins and signs a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Pregnancy or lactation period; 2. No sexual history; 3. Suspected of malignant disease; 4. The surgical time is greater than 3 hours; 5. History of 2 or more cesarean sections or abdominal surgeries; 6. Gynecological examination suspected posterior vaginal obstruction; 7. Patients with concomitant cardiovascular and pulmonary diseases.

Design outcomes

Primary

MeasureTime frame
Vital signs;Airway pressure;Pulmonary compliance;intraocular pressure;Lung ultrasound;—

Secondary

MeasureTime frame
Intraoperative sufentanil dosage;Intraoperative cis-atrakomide dosage;Intraoperative nitroglycerin dosage;Interoperative hydroxylamine dosage;Changes in perioperative C-reactive protein;surgery time;Anesthesia time;Surgical completion rate (non-transit rate);Abdominal pain 2 hours after surgery;Abdominal pain 12 hours after surgery;The amount of postoperative analgesic medication used;Incidence of postoperative vaginal pain;Incidence of postoperative abdominal pain;Incidence of postoperative shoulder pain;Incidence of postoperative nausea and vomiting;The time of the first disappearance after surgery;The time of the first postoperative meal;Incidence of other complications;—

Countries

China

Contacts

Public ContactCui Yu

Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China

fezxywb@qq.com+86 18040308150

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026